Loading company…
Sichuan Ingia Biosynthetic develops and manufactures ingredients using synthetic biology.
Founded in 2015 and based in Chengdu, Sichuan Ingia Biosynthetic makes stevia glycosides and other ingredients, including coenzyme Q10, vanillin, monk fruit glycosides and nicotinamide mononucleotide. Its products are used in food, beverages and supplements. It raised Series A funding in March 2022 from Addor Capital and Series A+ funding in September 2025 from Sinovation Ventures and Addor Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in